completed

The objective of PIAAF SCREEN AF was to offer primary care patients, aged 75 years and older, new technologies to detect atrial fibrillation (AF) using a wearable ECG patch and a blood pressure machine that has the ability to detect AF.

The aim was to establish a practical and cost-effective screening strategy that could be easily applied in primary care for early detection and treatment of AF. The SCREEN-AF trial is a Canadian multicenter study of atrial fibrillation (AF) screening being conducted in a home based setting.

Primary outcome:

The new diagnosis of ECG-confirmed atrial fibrillation or flutter within six months post-randomization.

Co-Principal Investigators, with Jeff Healey of PHRI, were:

  • Rolf Watcher, University of Goettingen
  • Noah Ivers, Women’s College Hospital
  • David Gladstone, Sunnybrook Hopsital
  • Russell Quinn, Libin Cardiovascular Institute of Alberta
Study Type

Interventional - Device

Study Design

Cohort study

NO. of Countries

2

NO. of Sites

32

NO. of Participants

856

Study Period

2015 - 2019

Sponsor

PHRI

Canadian Institutes of Health Research (CIHR)

Canadian Stroke Prevention Intervention Network (C-SPIN)

Boehringer Ingelheim

Heart and Stroke Foundation

iRhythm Technologies Inc. (grant in kind)

Back To Top